NAS in 2012: launch tally is century's best
This article was originally published in Scrip
Executive Summary
R&D in the international pharmaceutical industry appears in ruder health than some might think. In 2012, the number of new active substances (NAS) launched in their first markets worldwide hit 39 – the highest tally since 2000, new research from Scrip Intelligence has found.